Sponsor:
Mayo Clinic
Code:
NCT05654506
Conditions
Proliferative Glomerulonephritis With Monoclonal IgG Deposits
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Daratumumab
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-02-13. This information was provided to ClinicalTrials.gov by Mayo Clinic on 2025-09-16.